Burden and trends of diabetes mellitus in Ethiopia: systematic analysis of the Global Burden of Disease Study 1990–2023

Abstract

Aim: Diabetes mellitus is a growing non-communicable disease (NCD) imposing major health and economic burdens in Ethiopia. While prior national and subnational estimates have been published using Global Burden of Disease (GBD) 2019 data, this study provides novel, updated estimates reflecting newly delineated regional boundaries and recent socio-demographic shifts using GBD 2023 data. We aimed to estimate the national and subnational burden and trends of diabetes mellitus in Ethiopia from 1990 to 2023.

Methods: This analysis is part of the GBD 2023 study, a collaborative effort between the Ethiopian Public Health Institute and the Institute for Health Metrics and Evaluation. Estimates were generated using standard GBD modeling tools [DisMod-MR 2.1 and Cause of Death Ensemble modeling (CODEm)] for incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and DALYs [with 95% uncertainty intervals (UI)] across Ethiopia’s regions and city administrations.

Results: In 2023, Ethiopia’s age-standardized prevalence of all forms of diabetes mellitus (type 1 and type 2 combined) was 2,996.4 (95% UI: 2,704.8–3,269.5) cases per 100,000 population. Type 2 diabetes accounted for nearly 99% of cases. The Somali region had the lowest prevalence (2,243.1 per 100,000), about 45% lower than in Sidama (4,066.4 per 100,000), highlighting marked regional disparities. The age-standardized DALY rate was 1,124.2 per 100,000. While high fasting plasma glucose was the leading proximal risk factor, high body mass index ranked as the top upstream modifiable risk factor (264.1 DALYs per 100,000).

Conclusions: This study highlights the substantial and unevenly distributed burden of diabetes mellitus in Ethiopia, driven predominantly by type 2 diabetes and modifiable metabolic risk factors. These findings call for tailored, region-specific strategies, such as targeted obesity prevention in high-prevalence urban centers and strengthened health system capacity in high-mortality pastoral regions to curb the future burden and align with global NCD targets.

Keywords

diabetes mellitus / type 2 diabetes / Global Burden of Disease / Ethiopia / subnational estimates / DALYs / trends 1990–2023

References

[1] IDF Diabetes Atlas 10th Edition 2021 [Internet]. International Diabetes Federation; c2026 [cited 2026 May 17]. Available from: https://idf.org/news-and-resources/resources/idf-diabetes-atlas-2021/

[2] Ethiopian Public Health Institute (EPHI). Ethiopia STEPS Report on Risk Factors for Non-Communicable Diseases and Prevalence of Selected NCDs. Addis Ababa, Ethiopia: Ethiopian Public Health Institute; 2016.

[3] GBD 2023 Disease and Injury and Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025; 406: 1873-922.

[4] Stevens GA, Alkema L, Black RE, Boerma JT, Collins GS, Ezzati M, et al.; The GATHER Working Group. Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement. Lancet. 2016; 388: e19-23.

[5] GBD 2023 Causes of Death Collaborators. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet. 2025; 406: 1811-72.

[6] GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403: 2133-61.

[7] GBD 2019 Ethiopia Subnational-Level Disease Burden Initiative Collaborators. Progress in health among regions of Ethiopia, 1990-2019: a subnational country analysis for the Global Burden of Disease Study 2019. Lancet. 2022; 399: 1322-35.

[8] Ethiopian Statistical Service (ESS). Inter-Censal Population Survey (ICPS) and Population Projection (2007-2037) [Internet]. Addis Ababa: ESS; c2026 [cited 2026 May 17]. Available from: https://ess.gov.et/download/icps-population-projection-2007-2037-produced-in-2012-2/

[9] Mbanya JC, Motala AA, Sobngwi E, Assah FK, Enoru ST. Diabetes in sub-Saharan Africa. Lancet. 2010; 375: 2254-66.

[10] Hall V, Thomsen RW, Henriksen O, Lohse N. Diabetes in Sub Saharan Africa 1999-2011: epidemiology and public health implications. A systematic review. BMC Public Health. 2011; 11: 564.

[11] Katte JC, Sibomana L, Hapunda G, Cikomola JC, Abidha CA. Diabetes in sub-Saharan Africa: what are the next steps? Lancet Diabetes Endocrinol. 2022; 10: 766-8.

[12] Kengne AP, Amoah AG, Mbanya JC. Cardiovascular complications of diabetes mellitus in sub-Saharan Africa. Circulation. 2005; 112: 3592-601.

[13] NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants. Lancet. 2016; 387: 1513-30.

[14] Zheng Y, Ley SH, Hu FB. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2018; 14: 88-98.

[15] Abebe SM, Berhane Y, Worku A, Alemu S, Mesfin N. Level of sustained glycemic control and associated factors among patients with diabetes mellitus in Ethiopia: a hospital-based cross-sectional study. Diabetes Metab Syndr Obes. 2015; 8: 65-71.

[16] Berhe KK, Mselle LT, Gebru HB. The magnitude of chronic diabetes complications and its associated factors among diabetic patients attending the general hospitals in Tigray region, Northern Ethiopia. PLoS One. 2023; 18: e0290240.

[17] Wei H, Liu S, Liao Y, Ma C, Wang D, Tong J, et al. A Systematic Review of the Medicinal Potential of Mulberry in Treating Diabetes Mellitus. Am J Chin Med. 2018; 46: 1743-70.

[18] Xu R, Bai Y, Yang K, Chen G. Effects of green tea consumption on glycemic control: a systematic review and meta-analysis of randomized controlled trials. Nutr Metab (Lond). 2020; 17: 56.

[19] Misganaw A, Haregu TN, Deribe K, Tessema GA, Deribew A, Melaku YA, et al. National mortality burden due to communicable, non-communicable, and other diseases in Ethiopia, 1990-2015: findings from the Global Burden of Disease Study 2015. Popul Health Metr. 2017; 15: 29.

[20] GBD 2015 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016; 388: 1603-58.

[21] GBD 2016 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017; 390: 1345-422.

[22] Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, et al.; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Blood Glucose). National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet. 2011; 378: 31-40.

[23] Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 [Internet]. WHO; c2026 [cited 2026 May 17]. Available from: https://www.who.int/publications/i/item/9789241506236

[24] Global report on diabetes [Internet]. WHO; c2026 [cited 2026 May 17]. Available from: https://www.who.int/publications/i/item/9789241565257

[25] Saving Lives, Spending Less: The Case for Investing in Noncommunicable Diseases [Internet]. Geneva: WHO; c2026 [cited 2026 May 17]. Available from: https://www.who.int/publications/i/item/9789240041059

[26] GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020; 396: 1204-22.

[27] Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non communicable diseases: Executive summary [Internet]. WHO; c2026 [cited 2026 May 17]. Available from: https://www.who.int/publications/m/item/political-declaration-of-the-third-high-level-meeting-of-the-general-assembly-on-the-prevention-and-control-of-non-communicable-diseases--executive-summary

[28] NCD Countdown 2030 collaborators. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. Lancet. 2018; 392: 1072-88.